Cytosorbents Restructuring Tuesday, September 8, 2026 0.00 Neutral

Cytosorbents to execute 1-for-20 reverse stock split

The company amended its charter to implement a reverse split effective September 8, 2026, which may affect liquidity. Company governance measures are standard.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day